MiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2

In this study, we examined the role of the miRNA miR-770-5p in cisplatin chemotherapy resistance in ovarian cancer (OVC) patients. miR-770-5p expression was reduced in platinum-resistant patients. Using a 6.128-fold in expression as the cutoff value, miR-770-5p expression served as a prognostic biom...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Henan, Yu, Xiaotang, Ding, Yanfang, Zhao, Jinyao, Wang, Guang, Wu, Xian, Jiang, Jiyong, Peng, Chun, Guo, Gordon Zhuo, Cui, Shiying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288183/
https://www.ncbi.nlm.nih.gov/pubmed/27449101
http://dx.doi.org/10.18632/oncotarget.10736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288183/
https://www.ncbi.nlm.nih.gov/pubmed/27449101
http://dx.doi.org/10.18632/oncotarget.10736

Ejemplares similares